Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Innovus Pharmaceuticals Announces Progress in Fulfilling the Regulatory and Manufacturing Steps to Receive Market Authorization for FlutiCare® in Canada

Business Wire Wednesday, 19 June 2019
Innovus Pharmaceuticals Announces Progress in Fulfilling the Regulatory and Manufacturing Steps to Receive Market Authorization for FlutiCare® in CanadaSAN DIEGO--(BUSINESS WIRE)--Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women's health and respiratory diseases, today announced that it has made significant progress on the regulatory and manufacturing steps needed to obtain market authorization from Health Canada to commerc
0
shares
ShareTweetSavePostSend
 

You Might Like


Recent related news from verified sources

Innovus Pharmaceuticals Announces that its Delta Prime Savings Club E-Commerce Marketplace is on Track for Annual Sales of Approximately $3 million in 2019

Innovus Pharmaceuticals Announces that its Delta Prime Savings Club E-Commerce Marketplace is on Track for Annual Sales of Approximately $3 million in 2019
SAN DIEGO--(BUSINESS WIRE)--Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage...
Business Wire

NSR: Satellite Manufacturing & Launch Services Market to Generate $225 Billion in Next Decade

Hybrid Architectures Key to Winning Big as Market Dramatically Shifts CAMBRIDGE, Mass., July 17, 2019 (GLOBE NEWSWIRE) -- NSR’s *Satellite Manufacturing and...
GlobeNewswire Also reported by •Proactive Investors

Glaucoma Therapeutics Market to Reach US$ 10,091.0 Mn by 2026, Increasing Prevalence of Glaucoma to Provide Impetus, says Fortune Business Insights

Key companies covered in the Glaucoma Therapeutics Market Research report include Merck & Co., Inc., Novartis AG, Allergan plc, Bausch & Lomb Incorporated, Teva...
GlobeNewswire

ICC International Cannabis to supply New Zealand’s NUBU with pharmaceutical THC, CBD products

ICC International Cannabis Corp (CSE:WRLD.U) (OTCMKTS:WLDCF) said Thursday that it has inked an exclusive supply and commercial rights agreement with medical...
Proactive Investors


Other recent news in Press Releases

Workforce talent a key challenge for HONG KONG retailers to win over customers and transform industry, KPMG and HKRMA analysis findsMensch und Maschine SOFTWARE SE discloses Half year report
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.